Your browser doesn't support javascript.
loading
Impact of capacity-limited binding on recombinant factor VIII and von Willebrand factor pharmacokinetics in hemophilia A rats.
Vargas Christensen, Isabell; Loftager, Mette; Rode, Frederik; Mørck Nielsen, Hanne; Kreilgaard, Mads; Larsen, Malte Selch.
Affiliation
  • Vargas Christensen I; Haemophilia Research, Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
  • Loftager M; Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.
  • Rode F; Haemophilia Research, Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
  • Mørck Nielsen H; Haemophilia Research, Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
  • Kreilgaard M; Department of Pharmacy, University of Copenhagen, Copenhagen, Denmark.
  • Larsen MS; Haemophilia Research, Global Drug Discovery, Novo Nordisk A/S, Maaloev, Denmark.
J Thromb Haemost ; 17(6): 964-974, 2019 06.
Article in En | MEDLINE | ID: mdl-30924607
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor VIII / Von Willebrand Factor / Hemophilia A Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country: Denmark Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Factor VIII / Von Willebrand Factor / Hemophilia A Type of study: Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: J Thromb Haemost Journal subject: HEMATOLOGIA Year: 2019 Document type: Article Affiliation country: Denmark Country of publication: United kingdom